open access

Vol 72, No 4 (2021)
Clinical vignette
Submitted: 2021-05-19
Accepted: 2021-06-27
Published online: 2021-07-12
Get Citation

A woman with a 13-year history of anaplastic thyroid cancer

Piotr Stanisław Szczęsny1, Grażyna Orlicz-Szczęsna2
DOI: 10.5603/EP.a2021.0067
·
Pubmed: 34292575
·
Endokrynologia Polska 2021;72(4):420-421.
Affiliations
  1. Medical Faculty, Medical University of Gdansk, Gdansk, Poland
  2. Medical Centre — Endocrinology Polyclinic, Lublin, Poland

open access

Vol 72, No 4 (2021)
Clinical Vignette
Submitted: 2021-05-19
Accepted: 2021-06-27
Published online: 2021-07-12

Abstract

Not required for Clinical Vignette.

Abstract

Not required for Clinical Vignette.

Get Citation

Keywords

anaplastic thyroid carcinoma; treatment; survival

About this article
Title

A woman with a 13-year history of anaplastic thyroid cancer

Journal

Endokrynologia Polska

Issue

Vol 72, No 4 (2021)

Article type

Clinical vignette

Pages

420-421

Published online

2021-07-12

DOI

10.5603/EP.a2021.0067

Pubmed

34292575

Bibliographic record

Endokrynologia Polska 2021;72(4):420-421.

Keywords

anaplastic thyroid carcinoma
treatment
survival

Authors

Piotr Stanisław Szczęsny
Grażyna Orlicz-Szczęsna

References (9)
  1. Maitra A. Układ dokrewny. In: Kumar V, Abbas AK, Aster JC. ed. Robbins Patologia. Edra Urban&Partner, Wrocław 2019: 892–895.
  2. Drewa G, Ferenc T. Medical genetics [in Polish]. Elsevier Urban&Partner, Wrocław 2011: 148–152.
  3. Daroszewski J, Paczkowska K, Jawiarczyk-Przybyłowska A, et al. Anaplastic thyroid carcinoma with rapie thyrotoxicosis — a case report and the literature review. Endokrynol Pol. 2018; 69(1): 28–31.
  4. Abe I, Lam AKY. Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging. Histol Histopathol. 2021; 36(3): 239–248.
  5. Oh JiM, Baek SeH, Gangadaran P, et al. A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer. Thyroid. 2020; 30(4): 501–518.
  6. Jarząb B, Dedecjus M, Słowińska-Klencka D, et al. Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update. Endokrynol Pol. 2018; 69(1): 34–74.
  7. Mirabile A, Biafora M, Giordano L, et al. Uncommon Site of Metastasis and Prolonged Survival in Patients with Anaplastic Thyroid Carcinoma: A Systematic Review of the Literature. Cancers (Basel). 2020; 12(9).
  8. Ferrari SM, Elia G, Ragusa F, et al. Novel treatments for anaplastic thyroid carcinoma. Gland Surg. 2020; 9(Suppl 1): S28–S42.
  9. Lennon P, Deady S, Healy ML, et al. Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy. Head Neck. 2016; 38 Suppl 1: E1122–E1129.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl